Papers
2
Total Citations
141
H-Index
2
About
Paolo De Martini is a leading figure in the advancement of minimally invasive surgical oncology, with a primary focus on gastrointestinal and pancreatic cancers. His most impactful work centers on refining complex oncologic resections—specifically, subtotal gastrectomy with D2 lymphadenectomy for distal gastric adenocarcinoma and the artery-first approach (AFA) during minimally invasive pancreatoduodenectomy (MIPD) for pancreatic cancer. De Martini’s landmark 2010 study on subtotal gastrectomy with D2 dissection demonstrated that a minimally invasive approach could achieve excellent oncologic outcomes, reporting a 5-year survival rate that helped establish laparoscopic gastrectomy as a viable standard of care—a contribution that has garnered 139 citations. More recently, he has pioneered the application of the AFA in both laparoscopic and robotic pancreatoduodenectomy, showing that this technique, previously validated in open surgery, can be safely and effectively translated to MIPD. His comparative analysis of robotic versus laparoscopic platforms provides crucial data for surgical decision-making. With a career marked by technical innovation and rigorous outcomes research, De Martini continues to shape the future of minimally invasive cancer surgery, pushing the boundaries of what is achievable through the laparoscope and robotic console.
Research Focus
Key Achievements
Top Papers
- 1
- 2